Literature DB >> 15692086

Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins.

Susan M Dallabrida1, Nesreen Ismail, Julianne R Oberle, Blanca E Himes, Maria A Rupnick.   

Abstract

Cardiac myocyte loss, regardless of insult, can trigger compensatory myocardial remodeling leading to heart failure. Identifying mediators of cardiac myocyte survival may advance clinical efforts toward myocardial preservation. Angiopoietin-1 limits ischemia-induced cardiac injury. This benefit is ascribed to angiogenesis because the receptor, tie2, is largely endothelial-specific. We propose that direct, non-tie2 interactions of angiopoietin-1 on cardiac myocytes contribute to this cardioprotection. We found that mouse C2C12 skeletal myocytes lack tie2, yet dose-dependently adhered to angiopoietin-1 and angiopoietin-2 similarly to laminin, fibronectin, vitronectin, and more than to collagen-I, -III, and -IV. Adhesion was divalent cation-mediated (Mn2+, Ca2+, not Mg2+), blocked with EDTA/EGTA, RGD-based peptides, and select integrin subunit antibodies. Similar findings were obtained with human skeletal myocytes (HSMs) and freshly isolated rat neonatal cardiac myocytes (NCMs). Furthermore, angiopoietin-1 conferred significant survival advantage exceeding that of most cell matrices, which was not fully explained by differences in cell adhesion. Angiopoietin-1 promoted survival of serum-starved C2C12, HSM, and NCM (MTT, trypan blue) and prevented taxol-induced apoptosis (caspase-3). Immobilized and soluble angiopoietin-1 phosphorylated Akt(S473) and MAPK(p42/44), (not FAK(Y397)) in C2C12 more than in endothelial cells and more than did angiopoietin-2 or cell matrices. EDTA, RGD-based peptides, and some integrin antibodies blocked these responses. Angiopoietin-1 activated HSM and NCM Akt(S473) and MAPK(p42/44) survival pathways. We propose that this novel function contributes to developmental and cardioprotective actions of angiopoietin-1 presently attributed to vascular effects alone. Angiopoietin-1 may prove therapeutically valuable in cardiac remodeling by supporting myocyte viability and preserving pump function. The full text of this article is available online at http://circres.ahajournals.org.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692086     DOI: 10.1161/01.RES.0000158285.57191.60

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  68 in total

1.  Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2.

Authors:  Shai Y Schubert; Alejandro Benarroch; Juan Monter-Solans; Elazer R Edelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-27       Impact factor: 8.311

2.  The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation.

Authors:  Katelyn E Milam; Samir M Parikh
Journal:  Tissue Barriers       Date:  2015-04-03

Review 3.  Endothelial-cardiomyocyte interactions in cardiac development and repair.

Authors:  Patrick C H Hsieh; Michael E Davis; Laura K Lisowski; Richard T Lee
Journal:  Annu Rev Physiol       Date:  2006       Impact factor: 19.318

4.  Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade.

Authors:  Sae-Won Lee; Joo-Yun Won; Hae-Young Lee; Ho-Jae Lee; Seock-Won Youn; Ji-Young Lee; Chung-Hyun Cho; Hyun-Jai Cho; Seil Oh; In-Ho Chae; Hyo-Soo Kim
Journal:  Mol Med       Date:  2011-07-05       Impact factor: 6.354

Review 5.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

6.  Angiopoietin-1 peptide QHREDGS promotes osteoblast differentiation, bone matrix deposition and mineralization on biomedical materials.

Authors:  Nicole Feric; Calvin C H Cheng; M Cynthia Goh; Vyacheslav Dudnyk; Val Di Tizio; Milica Radisic
Journal:  Biomater Sci       Date:  2014-10-01       Impact factor: 6.843

7.  Inhibition of apoptosis in human induced pluripotent stem cells during expansion in a defined culture using angiopoietin-1 derived peptide QHREDGS.

Authors:  Lan T H Dang; Nicole T Feric; Carol Laschinger; Wing Y Chang; Boyang Zhang; Geoffrey A Wood; William L Stanford; Milica Radisic
Journal:  Biomaterials       Date:  2014-06-13       Impact factor: 12.479

Review 8.  Proinflammatory stem cell signaling in cardiac ischemia.

Authors:  Jeremy L Herrmann; Troy A Markel; Aaron M Abarbanell; Brent R Weil; Meijing Wang; Yue Wang; Jiangning Tan; Daniel R Meldrum
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 9.  Angiopoietin-2: development of inhibitors for cancer therapy.

Authors:  Bo Hu; Shi-Yuan Cheng
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

Review 10.  Integrin and growth factor receptor alliance in angiogenesis.

Authors:  Payaningal R Somanath; Alieta Ciocea; Tatiana V Byzova
Journal:  Cell Biochem Biophys       Date:  2008-12-02       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.